© Frontline Medical Communications 2018-2021. Reprinted with permission, all rights reserved.
Converge Coverage
PIONEER-HF Extension: Don’t stall starting sacubitril/valsartan
REPORTING FROM ACC 19
Related Articles
Catheter Ablation Versus Antiarrhythmic Drug Therapy for Ventricular Tachycardia
April 14, 2019
CLINICAL QUESTION: Among patients with ischemic cardiomyopathy and ventricular tachycardia, is catheter ablation or antiarrhythmic drug therapy a more effective initial strategy BACKGROUND:...
Monoclonal Antibody Abelacimab Compared to Rivaroxaban Had Lower Rates of Bleeding Complications
April 14, 2019
CLINICAL QUESTION: Can the inhibition of free factor XI with a monoclonal antibody be used for stroke prevention in Atrial fibrillation patients? BACKGROUND: Atrial fibrillation is a common...
Comparing Efficacy and Safety Between Patients with AF Taking DOACs or Warfarin After a DOAC Failure
April 14, 2019
CLINICAL QUESTION: Is warfarin better as a second-line anticoagulant than another direct oral anticoagulant (DOAC) in patients with atrial-fibrillation-induced ischemic strokes after failure of a...
Beta-Blockers Didn’t Reduce Mortality After Acute MI in Patients with Preserved Ejection Fraction
April 14, 2019
CLINICAL QUESTION: Do beta-blockers still reduce mortality after acute myocardial infarction (MI) in the modern era of faster and better reperfusion strategies? BACKGROUND: Beta-blockers have...